Boston Scientific Balance Sheet
NYSE: BSXHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Boston Scientific financial position
At the end of fiscal 2025, Boston Scientific reported total assets of $43.67 billion, up 10.9% from a year earlier against total liabilities of $19.20 billion. Shareholders' equity stood at $24.23 billion, or 55.5% of assets. The company held $1.97 billion in cash and equivalents against $11.44 billion of debt, a net debt position of $9.47 billion.
The current ratio (current assets divided by current liabilities) was 1.62, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.47.
Summary generated from market data by MetaCap's automated system. Methodology
Boston Scientific balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.97B | 414.00M | 865.00M | 928.00M | 1.93B | 1.73B | 217.00M | 146.00M | 188.00M | 196.00M |
| Receivables | 2.93B | 2.56B | 2.23B | 1.97B | 1.78B | 1.53B | 1.83B | 1.61B | 1.55B | 1.47B |
| Inventory | 2.94B | 2.81B | 2.48B | 1.87B | 1.61B | 1.35B | 1.58B | 1.17B | 1.08B | 955.00M |
| Total Current Assets | 8.79B | 6.92B | 6.51B | 5.76B | 6.32B | 6.69B | 4.70B | 4.00B | 3.82B | 3.24B |
| Property, Plant & Equipment | 4.04B | 3.29B | 2.86B | 2.45B | 2.25B | 2.08B | 2.08B | 1.78B | 1.70B | 1.63B |
| Goodwill | 18.28B | 17.09B | 14.39B | 12.92B | 11.99B | 9.95B | 10.18B | 7.91B | 7.00B | 6.68B |
| Intangible Assets | 7.02B | 6.68B | 6.00B | 5.90B | 6.12B | 5.92B | 7.89B | 6.37B | 5.84B | 5.88B |
| Total Assets | 43.67B | 39.40B | 35.14B | 32.47B | 32.23B | 30.78B | 30.57B | 21.00B | 19.04B | 18.10B |
| Accounts Payable | 1.14B | 960.00M | 942.00M | 862.00M | 794.00M | 513.00M | 542.00M | 349.00M | 530.00M | 447.00M |
| Short-Term Debt | 299.00M | 1.78B | 531.00M | 20.00M | 261.00M | 13.00M | 1.42B | 2.25B | 1.80B | 64.00M |
| Total Current Liabilities | 5.44B | 6.40B | 4.93B | 3.80B | 4.27B | 3.68B | 4.87B | 5.26B | 5.65B | 3.59B |
| Long-Term Debt | 11.14B | 8.97B | 8.57B | 8.91B | 8.80B | 9.13B | 8.59B | 4.80B | 3.81B | 5.42B |
| Total Liabilities | 19.20B | 17.39B | 15.61B | 14.90B | 15.61B | 15.45B | 16.69B | 12.27B | 12.03B | 11.36B |
| Shareholders' Equity | 24.23B | 21.77B | 19.28B | 17.57B | 16.62B | 15.33B | 13.88B | 8.73B | 7.01B | 6.73B |
| Retained Earnings | 5.57B | 2.67B | 819.00M | -750.00M | -1.39B | -2.38B | -2.25B | -6.95B | -8.39B | -8.58B |
| Total Debt | 11.44B | 10.75B | 9.10B | 8.94B | 9.06B | 9.14B | 10.01B | 7.06B | 5.62B | 5.48B |
| Net Cash (Debt) | -9.47B | -10.33B | -8.24B | -8.01B | -7.14B | -7.41B | -9.79B | -6.91B | -5.43B | -5.29B |
| Shares Outstanding | — | — | — | — | — | — | 1.39B | 1.38B | 1.37B | 1.36B |
This table shows 10 annual periods of Boston Scientific's balance sheet, from FY 2025 back to FY 2016, across 18 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow BSX's reporting calendar. What is a balance sheet?